BioNotebook: Xencor regains rights from Amgen; plus three other deals
This article was originally published in Scrip
Executive Summary
Xencor gains greater control in Amgen pact; Zogenix buys Brabant Pharma; CTI BioPharma buys worldwide rights to tosedostat; and Takeda licenses Mersana ADC.